7 must-reads for supply chain leaders this week

Here are seven articles Becker's Hospital Review published in the last week, highlighting an amino acids shortage exacerbated by manufacturing issues in Puerto Rico, and CVS' launch of free same-day delivery services in New York City, among other topics.

1. Walgreens rebrands in wake of CVS-Aetna deal
Walgreens unveiled a rebranding strategy aimed at attracting a younger customer demographic to remain competitive in the retail pharmacy sphere. 

2. FDA warns of a new product shortage worsened by Hurricane Maria: 4 things to know
Hospitals across the U.S. are already facing critical shortages of IV fluids after Hurricane Maria damaged manufacturing plants in Puerto Rico, and now the FDA is warning of a new product shortage exacerbated by the storm — injectable amino acids for severely ill patients and premature babies. 

3. Amazon withdraws application for pharmacy license in Maine
Amazon reportedly rescinded an application for a wholesaler pharmaceutical license in Maine.

4. Supply chain tip of the day: 3 pointers for a better value analysis committee
Rick Ngo, MD, a private practice general surgeon at Houston-based Southwest Surgical Associates, knows what it takes to manage a successful value analysis committee. 

5. FDA issues final guidance on UDI direct marking requirements: 4 things to know
The FDA published a final guidance Nov. 17 on unique device identifier marking requirements.

6. CVS starts free same-day prescription delivery in Manhattan: 3 things to know
CVS Pharmacy rolled out a free same-day prescription delivery service in New York City's Manhattan borough this week. 

 7. WHO to review Sanofi's dengue vaccine after evidence suggests it could worsen the disease
The World Health Organization will conduct a review of pharmaceutical giant Sanofi's dengue vaccine by year-end after evidence surfaced suggesting the vaccine could worsen the disease in some cases.

More articles on supply chain:
Pfizer to launch generic version of Viagra at $33 per pill
FDA urges drugmaker to recall osteoarthritis product following liver and lung injury reports
Amazon withdraws application for pharmacy license in Maine


© Copyright ASC COMMUNICATIONS 2018. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.


Top 40 Articles from the Past 6 Months